Literature DB >> 358212

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men.

A Szczeklik, R J Gryglewski, R Nizankowski, J Musiał, R Pietoń, J Mruk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 358212     DOI： 10.1016/s0031-6989(78)80053-8

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN： 0031-6989


× No keyword cloud information.
  14 in total

Review 1.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 2.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

Review 3.  Prostaglandins and the cardiovascular system.

Authors:  J R Vane
Journal:  Br Heart J       Date:  1983-05

4.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

5.  Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.

Authors:  A H Gershlick; D Spriggins; S W Davies; Y D Syndercombe Court; J Timmins; A D Timmis; M T Rothman; C Layton; R Balcon
Journal:  Br Heart J       Date:  1994-01

6.  Release of prostacyclin from the human pulmonary vascular bed in response to cholinergic stimulation.

Authors:  R Brandt; A Dembińska-Kieć; R Korbut; R J Gryglewski; J Nowak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

7.  A lack of effect of captopril on platelet aggregation in patients with congestive heart failure.

Authors:  I F Gow; A D Flapan; M Morris; E Davies; B C Williams; P L Padfield; T R Shaw; C R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 8.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

9.  Effect of insulin treatment on prostacyclin in experimental diabetes.

Authors:  H E Harrison; A H Reece; M Johnson
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

10.  Haemodynamic changes induced by prostacyclin in man.

Authors:  J Szczeklik; A Szczeklik; R Nizankowski
Journal:  Br Heart J       Date:  1980-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.